Sorry - There were no pages found that contain that search phrase.
 |
 |
 |
 |
|
 |
Previous 25 Showing Treatment 26 to 50 of 136 Next 25 |
 |
Location |
 |
Last Updated |
 |
 |
 |
Details |
 |
A Phase I Study of Vorinostat [Suberoylanilide Hydroxamic Acid (SAHA)] in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
Los Angeles, CA USA |
 |
04/15/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Loma Linda, CA USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Sacramento, CA USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Pomona, CA USA |
 |
04/11/2008 |
 |
 |
 |
Details |
 |
Phase III Trial Comparing Conventional Adjuvant Temozolomide with Dose-intensive Temozolomide in Patients with Newly Dignosed Glioblastoma |
 |
Sacramento, CA USA |
 |
04/11/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of GP96 Heat Shock Protein-Peptide Complex Vaccine in Patients With Recurrent or Progressive High-Grade Glioma |
 |
San Francisco, CA USA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
Phase ll Trial of Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Patients With Atypical or Malignant, Primary or Metastatic Brain Tumors of the Central Nervous System |
 |
Los Angeles, CA USA |
 |
03/02/2008 |
 |
 |
 |
 |
 |
Details |
 |
A Phase l Trial of Tumor Associated Antigen Pulsed Dendritic Cell Immunotherapy for Patients With Brain Stem Glioma and Glioblastoma |
 |
Los Angeles, CA USA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
Phase I Dose Escalation Study of Autologous Tumor Lysate-Pulsed Dendritic Cell Immunotherapy for Malignant Gliomas in Pediatric Patients |
 |
Los Angeles, CA USA |
 |
03/02/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Study of Glioma-Associated Antigen (GAA) Peptide-Pulsed Dendritic Cell Vaccination in Malignant Glioma Patients |
 |
Los Angeles, CA USA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
A Phase l Trial of Surgical Resection With Gliadel Wafer Placement Followed by Vaccination With Dendritic Cells Pulsed With Tumor Lysate for Patients With Malignant Glioma
|
 |
Los Angeles, CA USA |
 |
03/02/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase I Study of Immunization With Autologous Tumor Lysate-Pulsed Dendritic Cells in Patients With Malignant Gliomas (Vaccine Therapy in Treating Patients With Malignant Glioma) |
 |
Los Angeles, CA USA |
 |
03/02/2008 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
La Jolla, CA USA |
 |
03/01/2008 |
 |
 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
Sacramento, CA USA |
 |
03/01/2008 |
 |
 |
 |
Details |
 |
NTI 0501: An Open-Labeled, Extended-Use of Human Corticotropin-Releasing Factor (hCRF) (Xerecept) Intended for Patients Who Participate in Dexamethasone-Sparing Studies NTI 0302 or NTI 0303 |
 |
Palo Alto, CA USA |
 |
03/01/2008 |
 |
 |
 |
 |
 |
Details |
 |
Phase II Study Of 7 Days On/7 Days Off Temozolomide In Patients With High-Grade Glioma |
 |
San Francisco, CA USA |
 |
01/17/2008 |
 |
 |
 |
Details |
 |
Gliogene: Brain Tumor Linkage Study |
 |
San Francisco, CA USA |
 |
01/17/2008 |
 |
 |
 |
 |
 |
Details |
 |
NABTC 04-03: A Phase I Study of Vorinostat (Suberolyanilide Hydroxamic Acid [SAHA]) in Combination with Temozolomide in Patients with Malignant Gliomas |
 |
San Francisco, CA USA |
 |
10/03/2007 |
 |
 |
 |
Details |
 |
Phase I/II trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine For Patients With Recurrent High Grade Glioma |
 |
San Francisco, CA USA |
 |
10/03/2007 |
 |
 |
 |
 |
 |
Details |
 |
NABTC 04-02: Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma
|
 |
Los Angeles, CA USA |
 |
10/03/2007 |
 |
 |
 |
Details |
 |
A Phase II Study of Temozolomide (temodar) in the Treatment of Adult Patients with
Supratentorial Low Grade Glioma |
 |
San Francisco, CA USA |
 |
10/03/2007 |
 |
 |
 |
 |
 |
Details |
 |
A Pharmacokinetic and Pharmacogenomic Study of Patients With High-Grade Gliomas Receiving Daily Radiation Therapy and Temozolomide |
 |
Duarte, CA USA |
 |
08/31/2007 |
 |
 |
 |
Details |
 |
A Phase II Pilot Trial of Radiation Therapy With Concurrent and Adjuvant Temozolomide, Tamoxifen and Carboplatin (T2C) in the Treatment of Patients With Primary Central Nervous System Malignant Gliomas |
 |
Vista, CA USA |
 |
08/20/2007 |
 |
 |
 |
 |
 |
Details |
 |
Phase I/II Study of ZD6474 (ZactimaTM) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
 |
Los Angeles, CA USA |
 |
08/19/2007 |
 |
 |
 |
Details |
 |
A Pilot Multicenter Phase I/II Trial of RAD001 in Patients With Recurrent Glioblastoma Multiforme |
 |
Los Angeles, CA USA |
 |
08/19/2007 |
 |
 |
 |
 |
 |